Stay updated on Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.

Latest updates to the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4. This appears to be a minor metadata/template update with no effect on the study details or user-facing information.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe site revision has been updated to v3.5.3, replacing the previous v3.5.2. This appears to be a minor platform release and does not alter the study information or its presentation on the page.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check59 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. This update does not alter the study details or page content.SummaryDifference0.0%

- Check102 days agoChange DetectedRevision: v3.4.2 was added; the earlier notice about government funding status (v3.4.1) was removed.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Gemcitabine in UC Subjects Clinical Trial page.